Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00108 |
| Species: | Homo sapiens |
| Position : | chr11:100842300-100843050 |
| Year: | 2021 |
| Title: | Enhancer release and retargeting activates disease-susceptibility genes |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 34040254 |
| MONDO: | |
| Tissue: | Mammary gland |
| Tissue Ontology ID: | UBERON:0001911 |
| Cell Source: | MCF-7 |
| CVCL ID: | CVCL_0031 |
| Cell Type: | estrogen-responsive breast epithelial cell |
| Cell Ontology ID: | CL:0001070 |
| Experiment Type: | CRISPR promoter knockout, 4C-seq, ChIP-qPCR |
| High Throughput Method: | GRO-seq, CTCF ChIP-seq, histone profiling |
| Low Throughput Method: | RT-qPCR, cohesin siRNA knockdown |
| Target gene : | PGR |
| TF name : | FOXA1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXA1 | AndrogenReceptor | netpath | 167 |
| FOXA1 | Direct p53 effectors | pid | 141 |
| FOXA1 | FOXA1 transcription factor network | pid | 45 |
| FOXA1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| FOXA1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00107 | chr11:100842300-100843050 | Mammary gland | estrogen-responsive breast epithelial cell | -- |